Evolution of HER2 scores after neoadjuvant systemic therapy in breast cancer

被引：0
|
作者：
Chong, Esther G.
Jeon, Won Jin
Pham, Bryan
Castillo, Dan Ran
Mehta, Akhil
Pairawan, Seyed
Denham, Laura
Nagaraj, Gayathri
机构：
[1] Loma Linda Univ, Med Ctr, Loma Linda, CA USA
[2] Loma Linda Univ, Loma Linda, CA USA
[3] Loma Linda Univ, Sch Med, Div Med Oncol & Hematol, Loma Linda, CA USA
[4] Loma Linda Univ, Ctr Canc, Loma Linda, CA USA
[5] Loma Linda Univ, Dept Pathol, Loma Linda, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3139
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Evolution and Clinical Significance of HER2 Status after Neoadjuvant Therapy for Breast Cancer
    Shang, Jiuyan
    Liu, Yueping
    [J]. LABORATORY INVESTIGATION, 2023, 103 (03) : S209 - S209
  • [2] Prognostic significance and evolution of HER2 zero, HER2 low and HER2 positive in breast cancer after neoadjuvant treatment
    Wei, T.
    Wang, D.
    Peng, Y.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S301 - S302
  • [3] Optimal Regimen of Neoadjuvant Systemic Therapy for HER2 Positive Early Breast Cancer
    Lo, C.
    Wang, M. -Y.
    Kuo, W. -H.
    Lee, Y. -H.
    Tsai, L. -W.
    Lu, Y. -S.
    Lin, C. -H.
    Chang, D. -Y.
    Chen, W. -W.
    Huang, C. -S.
    [J]. BREAST, 2023, 68 : S61 - S62
  • [4] Change of HER2 status following neoadjuvant systemic therapy in primary breast cancer patients
    Yoshida, Atsushi
    Hayashi, Naoki
    Yagata, Hiroshi
    Suzuki, Koyu
    Nakamura, Seigo
    Yamauchi, Hideko
    [J]. CANCER RESEARCH, 2015, 75
  • [5] Impacts of HER2 immunohistochemical scores on response and outcomes of HER2-positive breast cancers after neoadjuvant therapy
    Chiu, Yun-Ning
    Hsu, Chih-Yi
    Lien, Pei-Ju
    Chao, Ta-Chung
    Liu, Chun-Yu
    Lin, Yen-Shu
    Wang, Yu-Ling
    Tsai, Yi-Fang
    Tseng, Ling-Ming
    [J]. JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2023, 86 (04) : 409 - 417
  • [6] Loss of HER2 expression in HER2-positive breast cancer patients after neoadjuvant therapy
    Sang, Yuting
    Wu, Jiong
    Yang, Benlong
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [7] PREOPERATIVE SYSTEMIC THERAPY FOR HER2 POSITIVE BREAST CANCER
    Ueno, Takayuki
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [8] PREOPERATIVE SYSTEMIC THERAPY FOR HER2 POSITIVE BREAST CANCER
    Ueno, Takayuki
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [9] Conversion of ER and HER2 Status After Neoadjuvant Therapy in Chinese Breast Cancer Patients
    Bo, Jiaqi
    Yu, Baohua
    Bi, Rui
    Xu, Xiaoli
    Cheng, Yufan
    Tu, Xi aoyu
    Bai, Qianming
    Yang, Wentao
    Shui, Ruohong
    [J]. CLINICAL BREAST CANCER, 2023, 23 (04) : 436 - 446
  • [10] Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients
    Guarneri, V.
    Dieci, M. V.
    Barbieri, E.
    Piacentini, F.
    Omarini, C.
    Ficarra, G.
    Bettelli, S.
    Conte, P. F.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (12) : 2990 - 2994
12345